17-6707069-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_177550.5(SLC13A5):c.190G>A(p.Val64Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_177550.5 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 25Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- amelocerebrohypohidrotic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- pyridoxine-dependent epilepsyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD2 exomes  AF:  0.00000398  AC: 1AN: 251356 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  6.84e-7  AC: 1AN: 1461792Hom.:  0  Cov.: 32 AF XY:  0.00  AC XY: 0AN XY: 727188 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 25    Uncertain:1 
This sequence change replaces valine with isoleucine at codon 64 of the SLC13A5 protein (p.Val64Ile). The valine residue is weakly conserved and there is a small physicochemical difference between valine and isoleucine. This variant is present in population databases (rs376024540, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with SLC13A5-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at